TrumpRx is a prescription drug website operated by the United States federal government.
Type of site | Prescription drug marketplace |
|---|---|
| Available in | English |
| Owner | White House Office |
| URL | trumprx.gov |
History
edit
In September 2025, Bloomberg News reported that Trump administration officials were considering establishing a website to partially fulfill U.S. president Donald Trump's demands that drugmakers reduce their prices to levels set by other countries.[1] On September 30, Trump announced TrumpRx from the Oval Office, joined by Pfizer chief executive Albert Bourla.[2] The website was set to go online in January 2026.[3]
Service
editTrumpRx is a website that offers prescription drugs at a discounted price.[2] The prices are benchmarked against those in Europe.[3] Pfizer's negotiated discounts ranged from fifty to eighty-five percent.[4]
The website does not sell drugs directly. Rather, it enables consumers to buy specific prescription medications directly from pharmaceutical companies at reduced prices, without going through their insurance. The aim is to reduce out-of-pocket expenses for consumers, especially those who pay cash or do not have extensive drug coverage.[5]
Drugs
editAccording to an initial statement from the Trump administration, TrumpRx will provide Eucrisa, Xeljanz, and Zavzpret.[2] In October 2025, the Trump administration reached a deal with AstraZeneca;[6] a website from AstraZeneca, named AstraZeneca Direct,[7] included Farxiga, Airsupra, and FluMist as eligible for direct pricing.[6] That month, EMD Serono agreed to offer its gonadotropin preparation drugs, including Gonal-f,[8] on TrumpRx.[9] AmgenNow, a website from Amgen that offers Repatha, is additionally set to appear on TrumpRx.[10]
Responses
editPolitical
editBloomberg News described TrumpRx as an instance of Trump using the federal government as an avenue for shareholder activism.[11]
Industry and health
editThe deal reached with the Trump administration secured Pfizer a reprieve from tariffs on the pharmaceutical industry, threatened to be one hundred percent.[12]
According to The New York Times, TrumpRx does not provide meaningful discounts for insurance beneficiaries.[13]
References
edit- ^ Zhang & Woodhouse 2025.
- ^ a b c Andrews, Whyte & Loftus 2025.
- ^ a b Robbins & Sanger-Katz 2025a.
- ^ Temple-West 2025.
- ^ "What is Trump's new Trumprx website and will it bring medicine prices down?". Al Jazeera. October 3, 2025. Retrieved November 17, 2025.
- ^ a b Robbins & Sanger-Katz 2025b.
- ^ Zhang, Muller & Furlong 2025.
- ^ Zhang, Nix & Wind 2025.
- ^ Kitchener et al. 2025.
- ^ Muller 2025.
- ^ Levine & Wagner 2025.
- ^ Garde, Zhang & Lowenkron 2025.
- ^ Robbins 2025.
Works cited
edit- Andrews, Rachel; Whyte, Liz; Loftus, Peter (September 30, 2025). "White House Unveils 'TrumpRx' Drug-Buying Site and a Pfizer Pricing Deal". The Wall Street Journal. Retrieved November 4, 2025.
- Garde, Damian; Zhang, Rachel; Lowenkron, Hadriana (September 30, 2025). "Pfizer's Drug Price Cuts Yield Three-Year Trump Tariff Reprieve". Bloomberg News. Retrieved November 4, 2025.
- Kitchener, Caroline; Pager, Tyler; Robbins, Rebecca; Kliff, Sarah (October 16, 2025). "Hailing an Era of 'Trump Babies,' White House Unveils I.V.F. Proposals". The New York Times. Retrieved November 4, 2025.
- Levine, Alexandra; Wagner, Kurt (October 13, 2025). "Trump's TikTok Deal Puts the White House in the Driver's Seat". Bloomberg News. Retrieved November 4, 2025.
- Muller, Madison (October 6, 2025). "New Amgen Website Offers Repatha at 60% Off After Trump Pressure". Bloomberg News. Retrieved November 4, 2025.
- Robbins, Rebecca; Sanger-Katz, Margot (September 30, 2025). "Trump Announces Deal With Pfizer to Sell Drugs to Medicaid at European Prices". The New York Times. Retrieved November 4, 2025.
- Robbins, Rebecca (October 1, 2025). "How Trump's Online Drugstore May Affect Your Drug Costs". The New York Times. Retrieved November 4, 2025.
- Robbins, Rebecca; Sanger-Katz, Margot (October 10, 2025). "Trump Announces a Deal on Drug Prices With AstraZeneca". The New York Times. Retrieved November 4, 2025.
- Temple-West, Patrick (September 30, 2025). "US announces direct-to-consumer 'TrumpRx' drug sales programme". Financial Times. Retrieved November 4, 2025.
- Zhang, Rachel; Woodhouse, Skylar (September 19, 2025). "US Weighs Trump-Branded Website to Help Shop for Cheaper Drugs". Bloomberg News. Retrieved November 4, 2025.
- Zhang, Rachel; Muller, Madison; Furlong, Ashleigh (October 10, 2025). "Trump Announces AstraZeneca Drug Price Cuts for Tariff Reprieve". Bloomberg News. Retrieved November 4, 2025.
- Zhang, Rachel; Nix, Jessica; Wind, Sonja (October 16, 2025). "Trump Strikes Deal With Merck KGaA on Tariffs, IVF Costs". Bloomberg News. Retrieved November 4, 2025.